The pursupplier(accordan

1. T

The vaccand expeand presincludingDiagnostProducti

The vaccPracticesdelivered

The vaccprocedurbe providof the pr

The vaccof-entry terms an

2. T

The vaccthe OIE Tests an

Within tthrough supplier(

The vaccBank witwithin ththe numadditiona

A buy-baOIE in or

The lengsupplier importansupplier((e.g. (no

Penalty cnot be re

               1 http://ww2 http://ww

pose of this(s) of PPR vance with the

The vaccine

cine produceerience in masented in theg OIE interntic Tests andon1.

cine supplies provided bd.

cine supplieres based onded by supprotocols used

cine supplier provision to nd conditions

The PPR Vac

cine produce internationalnd Vaccines fo

he framewor a Vaccine P(s) and the O

cine produceth as much he time allow

mber of doseal types of va

ack mechanirder to facilit

gth of time and the acnt factor to c(s) to respecn-exhaustive

clauses will espected (see

                      ww.oie.int/fileww.oie.int/file

s internationaccines in or criteria set o

producer(s) a

er(s) and supanufacturinge offer). The ational stand

d Vaccines fo

r(s) must beby relevant of

er(s) must c internationalying relevan

d.

(s) selected inspect the cs of the Contr

ccine Bank

er(s) and supl standards d

for Terrestrial

rk of this caProduction, QOIE.

ers’ and supp flexibility aswed and manes per vial oaccines (if de

sm for vaccitate flexibilit

between a ftual delivery

consider. Thct the lengthe) “emergenc

be inserted ie also 9. Fina

                       eadmin/Home/eeadmin/Home/e

nal call for rder to set uout below.

and supplier(

pplier(s) shou, quality con vaccines sudards as desor Terrestrial

e in possessfficial nation

omply with al standards t supporting

will allow the correspondinract which w

pplier(s) musdescribed in l Animals, Ch

ll for tenderQuality Contr

pliers’ offers ss possible, innage certain r bottle, andeveloped and

nes from they in the use

formal delivey of vaccinese OIE expec of time indy delivery”; “

in the Contraancial Penalt

eng/Health_staeng/Health_sta

tender is tp a PPR Vac

(s)

uld have refentrol, selling aupplied mustscribed in thel Animals, Ch

sion of a valnal authoritie

the relevant for all vaccing documentat

e OIE and/org production

will be signed

st comply w the latest Enhapter 1.1.10

, the term “rol, Storage,

should facilin order to e variables sud the capacd compliant).

e rolling stoc of the Vaccin

ery order of s to beneficcts the delaydicated in th “rapid delive

act, regardinglties).

andards/tahm/andards/tahm/

o select theccine Bank f

erences from and deliverint comply withe latest Enghapter 1.1.6

lid official ces for all pla

t quality assnes to be detion, as well

the donor(s)n and storage between the

ith relevant nglish version0: Internatio

Vaccine Ban Supply and

tate the settffectively an

uch as rollingity to manag

ck which are ne Bank.

PPR vaccinciary countriey to be as se contract.

ery”; “planne

g cases whe

/1.01.06_VAC/1.01.10_VAC

e most suitafor relevant c

m customers ng PPR vaccih relevant inlish version o: Principles

ertificate of nts producin

surance contlivered. Proo as a full and

) supporting e facilities, ine parties.

internationan of the OIE nal standards

nk” refers to Delivery Ag

ing up of a “d efficiently

g stocks and ge the produ

not used ma

nes from thees by the vahort as poss

Several optiod delivery”).

n the timelin

CCINE_PRODUCCINE_BANKS

able producecountries in

in multiple ines (to be innternational s of the OIE M of Veterinary

Good Manung the vaccin

trol programof of compliad detailed de

the project tn accordance

l standards E Manual of D

s for vaccine

o the service greement bet

“virtual” PPRy deliver the replenishmeuction and t

ay be propos

e OIE to theaccine supplsible and theons may be

ne agreed up

UCTION.pdf S.pdf

 

2

er(s) and Africa, in

countries ntroduced standards Manual of y Vaccine

ufacturing nes to be

mmes and nce must escription

to a right-e with the

including Diagnostic e banks2.

provided ween the

R Vaccine products ent rules, to supply

sed to the

e vaccine lier is an e vaccine proposed

pon would

 

3. L

The vaccvaccinesglobal, roffer) in logistic r

4. P

In the coand provindicated

The PPRstandardrelevant Animals

Neutraliswith the developeet al., 2eradicate

Vaccine

The vaccstrain. Inorigin ofanimals the straiabsence

Field tesand goat

The aptinew vacclivestock(Differeninternati

If the suwould be

Price anthe offerstandardcontrols;potency.

The vacc(internatasset.

The vaccvacuum least 2 yand prot

               3 http://ww

Location of t

cine produces pertaining tegional or na order to red

risks so that v

PPR Vaccine

ontext of thevide, or shod in the Cont

R vaccines pds for the qu parts of Cha (requiremen

sing antibod attenuated ed in India h010). This ied, following

strain and m

cine can be n the latter cf the strain; against PPRn to be able of reversion

sts should hat species, inc

tude of the cines such ak disease (entiate Infecteonal standar

upplier(s) hae interested i

d time constr, as well as

ds. This incl and the fi

cine should tionally recog

cine should and protecteyears at 2°C tected from l

                      ww.oie.int/file

he Vaccine B

er(s) and supto the Vaccinational level.

duce the logi vaccine deliv

es

e PPR Vaccinuld be abletract.

produced shoality of veteapter 2.7.11ts for PPR va

ies anti-PPR PPRV vaccinave been shnformation i

g mass and w

main characte

based on tcase, availab the level of R with the re to be excret to virulence

ave proven thcluding young

supplier(s) tas thermo-res.g. dual rec

ed from Vaccds will be an

as/have a pro in receiving i

traints assocs relevant guludes the vanal product

confer immugnised justif

have at leased from light. to 8°C (alth

light. If the

                       eadmin/Home/e

Bank

pplier(s) is/are Bank. The . Proposing dstic risks mivery is not dis

ne Bank, the to produce

ould meet thrinary vaccin

1 of the OIEaccines3).

RV were founne strain Nigown to produndicates tha

well-planned v

eristics

he Nigeria 7le supporting passages inecommendeded by inocul following at

hat the atteng and pregna

o produce (wsistant vaccincombinant vinated Anim

n important a

ogramme for nformation o

iated with thuarantees wialidation as batch tests

unity protectications prov

st 2 years of . PPR vaccinhough storage vaccine is de

eng/Health_sta

re wholly res OIE will not

different locaght be consisrupted).

e vaccine proe on time, t

he requiremene productionE Manual of

nd in sheep geria 75/1. Ouce strong imat PPR is a d vaccination c

75/1 strain og evidence s cell culture dose for vaated animals least three b

nuated PPR ant animals.

within the dunes, dual vacaccine againals) vaccines

additional ass

r developing on the progre

hose extra tyth regard to

a vaccine; for sterility

tion for at levided) longer

f remaining se freeze-driee at –20°C iescribed as

andards/tahm/

sponsible for t engage in thations for stoidered as an

oducer(s) andhe vaccines

ents for PPRn referred to Diagnostic T

and goats upOther attenuammunity as wdisease that

campaigns, a

of PPR or ohould be pro

e; the effecticcination fors and to spreback passage

vaccine is sa

uration of thccines allowinst PPR ans or any otheset.

new types ess of the pro

pes of vaccio the vaccine the methody and purity

east three yer protective

shelf-life beted in the Wey is better), pr a “thermosta

/2.07.11_PPR

producing ohe provision orage (that w additional a

d supplier(s) within the

R vaccines ao in -1- abov Tests and Va

p to three yeated PPR vacwell (Saravan can be well as was done f

n another wovided in theveness in prr at least 3 yead to in-cons in sheep.

afe for use i

e Contract, 3ng the proted Capripoxv

er type of vac

of vaccines ogramme.

nes should be’s complian of manufac, safety and

ears. Vaccine immunity wo

tween 2°C anybridge medirovided it is able vaccine

R.pdf

on time or st of storage fawill be detailasset (manag

should have shortest tim

and comply ve as well asaccines for T

ears after vaccines that hnan et al., 20 controlled,

for Rinderpes

well-known ate tender regaroviding prot

years; the inntact animals

n all breeds

30 Septembection againsirus infectioccines compl

in progress,

be clearly spence with intecture; the i

d efficacy, a

es with demould be an a

nd 8°C, storum can be k

stored unde” (vaccine p

 

3

toring the cilities at ed in the

gement of

e in stock me period

with OIE s with the

Terrestrial

accination have been 010; Sen and even st.

ttenuated arding the tection in nability of s; and the

of sheep

ber 2014) st another on), DIVA lying with

the OIE

ecified in ernational n-process nd batch

onstrated additional

red under kept for at r vacuum

presenting

 

an increcontaininpotency)additiona

Vaccine

The finaevidence

The vaccmethodspotency proof of

The vaccas well avaccine’sadminist

The seedshould bvirus shogoats) arecomme

Labelling

Detailed form andchain (or

The languse must

The whonumber correspodose viaprice.

Offers inOther us

Advice (would be

It is impthese vaemphasiexclusive

The vaccto supplythe Vacc

The tendin ECOW

All of the

               4 Current Bissau; L 

eased thermong trehalose,, the appropal asset.

Tests implem

l product wile of those tes

cine supplies of manufac and efficacy compliance v

cine supplieras a full ands characteristration proced

d should be cbe tested freeould be preseand have deended dose (

g and packag

labelling prod quality of tr on any relat

guages availat also be spe

le descriptio of boxes pending pricesls/bottles wo

ncluding avaser-friendly so

pros and cone welcome.

ortant to notaccines excls in some ely).

cination of cay PPR vaccincine Bank to

derer will havWAS countries

e above infor

                       ECOWAS Memiberia; Mali; N

ostability, e.g, or that alloriate publish

mented by th

ll be tested fsts.

r(s) will alsocture, the in in small rum

via the supp

(s)’ offer willd detailed destics includidures, volum

controlled ane from pestivent. The seedemonstrated (compliance

ging procedu

ocedures sho the labels usted constrain

able for the ecified.

on of the pacer pallet, etcs should be sould be an a

ilability of reolutions can

ns) from the

te that in theusively for

ECOWAS (E

amels and cane for camels include thes

ve to provide s.

rmation will b

                       mbers are: BeNiger; Nigeria;

g. using dehows a resistahed data will

he vaccine su

for safety and

o provide evin-process cominants, and ly of relevant

l also foreseeescription of ng method o

me per dose a

d tested freeiruses and ad should hav its efficac with these re

ures

ould be specsed, as well ants).

labelling and

ckaging (numc.) proposedspecified. Ofadditional as

eady-to-use be proposed

vaccine sup

e context of tsmall ruminEconomic Co

attle is not ens and cattle we species.

detailed evid

be treated in

nin; Burkina F Senegal; Sier

hydration of nce at 45°C be made ava

upplier(s)

d potency, a

dence of thntrol and th stability. Tht documentat

e the submis the protocol

of manufactand possible

e from bacterny other knove passed an y to protecequirements

cified in the as details on

d the langua

mber of dosesd should be ffers with prisset. The num

individual do (and describ

ppliers regard

this PPR Vacnants (goats ommunity o

nvisaged in t would be an

dence of exp

a confidenti

Faso; Cape Verrra Leone and

an attenuat for a periodailable. In th

nd the vacci

e PPR vaccie batch con

he vaccine sution.

ssion of all res used: a fu

ture, the kin secondary ef

rial, fungus awn extraneou innocuity te

ct sheep an should be do

offer, i.e. sun the timing

ages availabl

s per vial or detailed in ces coveringmber of dose

oses of vaccbed).

ding the diffe

cine Bank, t and sheep)of West Afri

the context o additional as

perience in d

ial manner.

rde; Côte d’Ivo Togo.

ted PPR vacd of 14 days is case it wil

ne supplier(s

ne’s validatintrol for idenpplier(s) will

elevant suppoll and detaild of diluent

ffects identif

and mycoplasus virus. Onlyest in animalsd goats ag

ocumented).

ch as inform of the labell

e for the vac

bottle, numb the offer. D both individes of vaccine

ines may be

erent types o

he OIE will r) in Africa, can States)

of this Vaccinsset for a pot

elivering PPR

oire; Gambia; G

ccine in an with minimll be conside

s) will have t

ion as a vacntity, sterilityl need to dem

orting documled descriptit and adjuvaied.

sma contamiy live attenus (rodents, s

gainst PPR

mation on theling in the p

ccine instruc

ber of bottlesDifferent optdual doses ae will depen

e an addition

of packaging

request the d probably w countries4

ne Bank. Thetential enlarg

R vaccines, e

Ghana; Guinea

 

4

excipient al loss of

ered as an

to provide

ccine, the y, safety, monstrate

mentation, on of the ant used,

nation. It ated PPR heep and with the

e content, roduction

ctions for

s per box, tions and nd multi-

nd on the

nal asset.

available

delivery of with more (but not

e capacity gement of

especially

a; Guinea-

 

5. D

The initiinitial coconsecut

6. S

The vaccthe vacc

It is antcommerccountry o

The PPRdelivery. order widestinatibe shippdestinaticountry.

The prop

- T

-

- b

- T

-

- D

- Dc

- T

Before aregardingbe includfinal cos

The maxshort as delays aoutlined the OIE,

7. M

Other se

(i)

(ii)

(iii)

Duration of t

al Contract wontract is 30tive amendm

Shipment of

cine supplierines to the a

ticipated thacial airport o of final desti

R vaccines m Shipping will specify theion, the requped. The PPion designat

posed detaile

Type of vacc

Number of b

Information bottles or via

Type of pack

Minimum siz

Different de“planned de

Documents certificate, a

The INCOTE

any shipmentg the proposded in the Cost and deliver

ximum delay possible. Thnd the corre and agreed financial pe

Miscellaneou

rvices relatin

Live Atte

Use of va

Availabil

he Contract

will have a m0 September

ments.

Vaccines

r(s) undertakirport of fina

at the deliveof the capitanation (in an

must be proill only take pe beneficiaryested numbeR vaccine med by the O

ed terms and

ine (strain/ty

ottles or vial

required to als);

kaging;

ze of the deli

elivery optiolivery”);

provided witirway bill (AW

RM condition

t takes placesed cost and ontract. The ry time of the

y between thhe vaccine sesponding tim upon in the nalties will b

us

ng for examp

enuated Vacc

alidated met

ity of differe

maximum dur 2014. The

ke(s) to assisal destination

ery of vaccinl city or at o

ny case, one a

perly stored place upon ty country (iner of doses (o

must be shipOIE and stor

conditions o

ype);

s in a shipme

complete a

very lots;

ns (e.g. (no

th the vacciWB), etc.);

ns shall be d

e, the vaccin the delivery delivery will e shipment b

e OIE order supplier(s)’ omes. The vac contract; sh

be applied.

le (not exhau

cines resistan

hods allowin

nt strains for

ration of two contract ma

st the OIE inn.

nes to the fone other ma airport per sh

and packagthe receipt ofncluding the or of vials/bopped by the red in the c

of shipment m

ent lot;

delivery ord

on-exhaustiv

ne delivered

detailed in th

e supplier(s)y time of the only take plaby the OIE.

and deliveryoffer should ccine supplihould a breac

ustive) to:

nt to hot tem

g to prove th

r the vaccine

years. The aay be extend

n organising

inal destinatain commerchipment or o

ged before sf a delivery o relevant benttles) and th

contractor(s)cold chain fa

must be desc

der (number

e): “emerge

d (invoice, c

e terms and

) will presen shipment. Tace after vali

y to various take into coer(s) must cch of contrac

perature con

he absence of

e;

anticipated coed by mutua

ground and

tion will takcial airport inrder of delive

shipment andorder from OIneficiary aute vaccine typ) to the airpacility indica

cribed as rega

of vaccine

ency delivery

certificate of

conditions of

t a financial The cost of tdation and w

countries innsideration tomply with tct occur with

nditions;

f replicating

ompletion daal agreemen

air transpor

ke place at n the relevanery).

d ready to uIE Headquarthority), the pe (type and port of the cated by the

ards:

doses or n

y”, “rapid

analysis, c

of shipment p

proposal to transportationwritten appro

n Africa shou the different the time schhout prior ap

pestiviruses;

 

5

ate of the t through

tation for

the main nt eligible

use upon ters. This

airport of strain) to country of recipient

umber of

delivery”,

onformity

proposed.

the OIE, n will not val of the

uld be as t possible hedule as pproval of

;

 

(iv)

(v)

(vi)

(vii)

(viii)

can be o

8. F

The priccriteria iregardingdifferent

- C(cf

- V

- Ts

The OIEstructureinsuranc

From exoptions wof vials/b

9. F

If the vasupplier(

Provision

Financiarequeste

10. S

The offeThe firstwill only

The vaccexamine exhaustiv

Developmvaccines

Vaccines

Scientifiand vacc

The vacc

) Insuranc

offered in the

Financial Co

ce of the serin the selectg the cost ot costing met

Cost of the V(total volumecontract). It fees (fixed co

Vaccine cost

The proceduspecified.

E expects ase (cost of vce, etc.). This

xperience, th with or withobottles, differ

Financial Pe

accine suppl(s) will be su

ns for heavy f

al penalties wed in accorda

Selection cri

r should be t selection pr be examined

cine produce all eligible ve and not b

ment of news);

s with immun

c collaboraticines for in-v

cine supplier

ce (insurance

e answer to th

nditions:

rvice as desction of the vof the servicthods, and pr

Vaccine Bane of the vac should also osts, if releva

per dose an

re used for c

s much tranvaccine prods information

he OIE encoout fixed costrent prices d

nalties:

ier(s) does/dbmitted to fi

financial pen

will also be ance with term

teria:

presented inrocess will bd for the offe

r(s) and sup offers officiy order of im

w types of va

nity protectio

on (e.g. avaitro tests or t

(s)’ commitm

e of vaccine s

his call for te

cribed abovevaccine suppce and the price structure

nk: price variccine bank u clearly isolaant) and the

d/or per vial/

calculating t

nsparency anuction, stora

n will be treat

urages vaccits, price scaepending on

do not respecnancial pena

nalties in cas

applied if thms and cond

n two parts: e made on t

ers retained a

plier(s) will bally received

mportance):

ccine and a

on over 3 yea

ilability free tests on anim

ment and serv

stock, when r

ender, and wo

e and the paplier(s). The payment cones, e.g.:

iation depenunder the coate the possi individual va

/bottle;

he cost of tr

nd detailed age cost, coted as confid

ine suppliersle depending speed of de

ct the condialties.

se of late deli

he vaccines, ditions of the

(i) the technhe basis of tafter the first

be selected bd in due tim

dvice on tho

ars;

of charge ofmals);

vices (rolling

relevant)

ould be addi

ayment cond vaccine supnditions. The

ding on the ontract with ble costs coariable cost o

ransportation

information ost of packadential and w

s to be creag on total nulivery / plann

tions mentio

ivery will be f

vials/bottles contract are

nical part, an the technicat selection.

by an ad hocme at OIE H

ose new vacc

f samples of

g system, spe

tional assets

itions propospplier(s) shoe offers may

quantity of the OIE forrresponding of the vaccine

and procure

as possibleaging, cost

will remain so

ative in theirmber of dose

ned productio

oned in the

foreseen in t

s, number of not availabl

nd (ii) the finl part. The fi

Selection Ceadquarters

cines (includ

f antigens, a

eed of deliver

s.

sed will be iould make a y be present

the vaccine r the duratio to the annuae;

ement shoul

e regarding t of labellingo.

r proposals: es purchasedon, etc.

contract, the

the contract.

f doses, or te in due tim

nancial part inancial part

Commission w on the basi

 

6

ding DIVA

ntiserum,

ry, etc.)

important proposal ted using

supplied on of the al service

d also be

the price , cost of

different d, on size

e vaccine

the strain e.

(pricing). t (pricing)

which will s of (not

 

- G

-

e

- Ctc

- F

- P

- P

Tendererof West proposedthe list odelivery

Tenderer

Please n

The finaSelection

11. C

All tendeand 9 (n

(i)

(ii)

               5 “CONFI« NE PASdesk / whOIE recep

Global exper

Nature and including paenvisaged in

Conditions ptime betweencountries;

Flexibility of

Price of the s

Payment con

rs are also in African Stad. They shou of countries (or indicative

rs may need

ote that all d

al decision wn Committee

Content of th

ers (both finaine) copies,

The Technbearing theenvelope be

The Financbearing theenvelope be

                      DENTIEL” (in

S OUVRIR À LAen received”.

ption desk staf

ience and su

quality of tackaging and Africa (poss

proposed regn a delivery

the Vaccine

services prop

nditions prop

nvited to speates, where ld provide th where they e reservations

to provide ad

documents re

will be takee.

he offer:

ancial and te marked “cop

ical Offer (oe words “Envearing the wo

cial Offer (ore words “Envearing the wo

                       n French) meaA RÉCEPTION This should bff handling inc

upply referenc

the vaccine d number ofibly both em

arding the ro order sent by

Bank, and th

posed;

osed.

cify the list they alreadye list of coun could not ds / logistical

dditional info

elating to the

n on the ba

chnical offerpy”. Each ten

riginal and nvelope A – Tords (as draft

E

NE P

riginal and nvelope B – Fords (as draft

E

NE P

ns: “ConfidentN » (in French)e written in Fr

coming mail ar

ces;

offered (cof doses per

mergency and

olling systemy the OIE an

he services o

of countries,y benefit frontries where

deliver PPR v concerns fro

ormation dur

e offer should

asis of the

rs) must be snder will be s

nine copies) Technical offted below5):

CONFID

Appel

Envelope A –

PAS OUVRIR

nine copies) Financial offted below):

CONFID

Appel

Envelope B –

PAS OUVRIR

tial”; “Appel d) means: “Do rench since Ore French spea

mpliance w vial or bot regular vacc

m (replenishmnd the expect

offered;

, particularlyom a marke they have alvaccines or om experienc

ing the selec

d be prepared

recommenda

submitted in submitted in

should be pfer” and the

DENTIEL

d’offres

Technical of

A LA RECEP

should be pfer” and then

DENTIEL

d’offres

Financial of

A LA RECEP

d’offres” (in Fr not open this IE Headquarteaking.

ith OIE intetle, given th

cinations);

ment of stocted time of d

y within the Eet authorisatready provide

may have ree or for legal

ction process

d in English.

ations made

one original, the following

placed and sn placed and

ffer

PTION

placed and sn placed and

fer

PTION

rench) means: mail at the froers are based i

ernational sthe condition

ck) and the delivery to be

Economic Cotion for the ed PPR vacc

estrictions fol reasons).

if required.

by the ind

, marked “org manner:

sealed in an d sealed into

sealed in an d sealed into

: “Call for tendont desk / rece in Paris, Franc

 

7

andards), ns of use

length of eneficiary

ommunity vaccines cines, and r vaccine

ependent

iginal”,

envelope o another

envelope o another

der” and eption ce and

 

All parts Any Tecconsider

The enveenvelope

(iii)

and shou

(iv)

Monsieu

Organisa

12, rue d

F-75017

France

The wordoffers are

12. P

The conDr. Alain

For the oDecembe

of the tendechnical Offeed as ineligib

elopes contaie and sealed.

uld be labelle

r le Directeu

ation Mondia

de Prony

7 Paris

ding (iii) on e sent throug

Procedure:

ntact personn Dehove (a.d

offer to be vaer 2012 at 1

er other than r that contable.

ining the Tec. The externa

ed as follows

r Général

le de la Sant

the envelopgh commerci

at the OIEdehove@oie.i

alid, it must 15.00 (Paris

the financiaains any fin

chnical Offer al envelope sh

NE PAS

s:

té Animale (O

pes should aal couriers o

E Headquartnt).

be deposited time) at OIE

al offer must nancial info

and the Finahould state i

CONFIDEN

OUVRIR A L

Appel d’of

OIE)

lso appear or quick mail

ters during

d and registe Headquarte

be submittedrmation will

ancial Offer mn large bold

TIEL

A RECEPTIO

ffres

on the outsid delivery serv

the period

red against rrs (address s

d in Envelope be automa

must be put letters:

ON

de of the (pvices.

of preparat

eceipt at thespecified und

e A – Techniatically rejec

into an exter

lastic) wrapp

tion of the

e latest on Mder -11(iv) - a

(End) -

 

8

cal Offer. cted and

rnal

per if the

offers is

onday 3rd above).

8 pages -